Therapy News and Research

RSS

Updated toolkit to guide global menopause care

Care for women with menopausal health issues should improve globally following the release of an updated Monash University-led toolkit that guides health professionals around the world in assessing and treating them.

30 Oct 2023

Does adding sigh breaths to the usual care of trauma patients receiving mechanical ventilation increase ventilator-free days?

Researchers investigated whether adding sigh breaths to standard care regimens of mechanically ventilated trauma patients increased ventilator-free days.

30 Oct 2023

How does the Mediterranean diet impact insulin resistance and sensitivity in obese individuals?

Researchers evaluate the associations between adherence to the Mediterranean diet, insulin secretion, resistance, and sensitivity in obese individuals.

30 Oct 2023

Stopping metformin early linked to higher dementia risk in older adults with type 2 diabetes

Early termination of metformin treatment in older adults with type 2 diabetes is associated with a higher risk of dementia, according to a cohort study. The research has significant implications for diabetes management, especially among those at higher risk for dementia.

29 Oct 2023

Machine learning sheds light on mental health challenges faced by HCWs during COVID-19 pandemic

Machine learning reveals unique mental health struggles among healthcare workers during the COVID-19 pandemic, highlighting the urgent need for specialized support. The study analyzed therapy transcripts to show how healthcare professionals faced distinct challenges, including heightened anxiety and depression.

29 Oct 2023

New study highlights risks of anti-ERBB2 cancer drugs during pregnancy

Study finds that anti-ERBB2 inhibitors used in breast cancer treatment pose significant risks to pregnancy and fetal health, including higher likelihoods of congenital defects and intrauterine growth restriction. Researchers recommend careful monitoring and possibly discontinuing these drugs during pregnancy despite their effectiveness against cancer.

29 Oct 2023

MHRA grants conditional marketing authorization for AbbVie's Tepkinly to treat aggressive blood cancer

AbbVie today announced that the UK Medicines and Healthcare products Regulatory Agency has granted conditional Marketing Authorisation for Tepkinly® (epcoritamab) as a monotherapy for the treatment of adults with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL), after two or more systemic therapies.

28 Oct 2023

Five ways AI can help to deal with the mental health crisis

Artificial intelligence is making waves in the world of health and beyond. And there are multiple ways that it can help people with their wellbeing and health, across mental and physical health.

28 Oct 2023

Study offers the most comprehensive look to date on prostate cancer disparities

Cedars-Sinai Cancer investigators have found that Black men respond as well as white men to systemic therapies for advanced prostate cancer when access to quality healthcare is equal, regardless of socioeconomic status.

27 Oct 2023

RF-CBT reduces rumination and shifts brain connectivity in adolescents with depression

A new study from The Ohio State University Wexner Medical Center and College of Medicine, University of Utah and University of Exeter (UK) substantiates previous groundbreaking research that rumination (overthinking) can be reduced through an intervention called Rumination-focused Cognitive Behavioral Therapy (RF-CBT).

27 Oct 2023

UC San Diego Health and Tri-City partnership aims to expand, transform access to health care

After open public discussion and a unanimous board vote, Tri-City Healthcare District ("Tri-City" or "District") announced yesterday that UC San Diego Health has been selected as the District's future health care partner.

27 Oct 2023

New treatment combination shows promise for metastatic colorectal cancer patients with rare genetic mutation

An international Phase 3 clinical trial found that metastatic colorectal cancer patients with a rare genetic tumor mutation called KRAS G12C experienced superior progression-free survival rates compared to standard of care when offered a combination treatment of KRAS inhibitor sotorasib and monoclonal antibody panitumumab.

27 Oct 2023

Novel replacement strategy holds promise for the treatment of various genetic disorders

Severe Combined Immunodeficiencies (SCIDs) are a group of debilitating primary immunodeficiency disorders, primarily caused by genetic mutations that disrupt T-cell development. SCID can also affect B-cell and natural killer cell function and counts.

27 Oct 2023

New drug candidate found to be highly effective in treating rare sight-threatening eye infection

A drug candidate, based on pioneering UCL and Moorfields Eye Hospital research and currently under development by SIFI S.p.A., has been found to be highly effective in treating a rare sight-threatening eye infection in a new international clinical trial.

26 Oct 2023

Microbubble-based biomarker could improve NIR-PIT treatment for cancer

Researchers at Nagoya University in Japan and their collaborators have used a biomarker based on microbubbles to evaluate the success of near-infrared photoimmunotherapy (NIR-PIT) treatment.

26 Oct 2023

Study shows phages can promote mammalian cellular growth and survival

Bacteriophages, also called phages, are viruses that infect and kill bacteria, their natural hosts. But from a macromolecular viewpoint, phages can be viewed as nutritionally enriched packets of nucleotides wrapped in an amino acid shell.

26 Oct 2023

Dato-DXd improves progression-free survival in patients with metastatic non-squamous NSCLC

Treatment with datopotamab deruxtecan (Dato-DXd), a novel Trop-2 directed antibody-drug conjugate, was found to significantly improve progression-free survival in patients with metastatic non-small cell lung cancer, an improvement that was primarily driven by patients with non-squamous tumors.

26 Oct 2023

UTHSC researcher part of team studying obesity-cancer connection

A University of Tennessee Health Science Center (UTHSC) researcher is a member of a prestigious team that has just received a highly competitive Endeavor Award totaling $3 million from The Mark Foundation for Cancer Research.

26 Oct 2023

New nanoparticle-based system developed for comprehensive treatment of rheumatoid arthritis

A team of scientists led by KOO Sagang from the Seoul National University and Center for Nanoparticle Research within the Institue for Basic Science Center (IBS), in collaboration with researchers from Korea Institute of Science and Technology (KIST) and the Seoul National University, developed a new solution for the treatment of rheumatoid arthritis (RA).

26 Oct 2023

New bioreactor could accelerate access to cancer-killing immunotherapy

A new tool to rapidly grow cancer-killing white blood cells could advance the availability of immunotherapy, a promising therapy which harnesses the power of the body's immune response to target cancer cells.

26 Oct 2023

Therapy News and Research

Updated toolkit to guide global menopause care

Does adding sigh breaths to the usual care of trauma patients receiving mechanical ventilation increase ventilator-free days?

How does the Mediterranean diet impact insulin resistance and sensitivity in obese individuals?

Stopping metformin early linked to higher dementia risk in older adults with type 2 diabetes

Machine learning sheds light on mental health challenges faced by HCWs during COVID-19 pandemic

New study highlights risks of anti-ERBB2 cancer drugs during pregnancy

MHRA grants conditional marketing authorization for AbbVie's Tepkinly to treat aggressive blood cancer

Five ways AI can help to deal with the mental health crisis

Study offers the most comprehensive look to date on prostate cancer disparities

RF-CBT reduces rumination and shifts brain connectivity in adolescents with depression

UC San Diego Health and Tri-City partnership aims to expand, transform access to health care

New treatment combination shows promise for metastatic colorectal cancer patients with rare genetic mutation

Novel replacement strategy holds promise for the treatment of various genetic disorders

New drug candidate found to be highly effective in treating rare sight-threatening eye infection

Microbubble-based biomarker could improve NIR-PIT treatment for cancer

Study shows phages can promote mammalian cellular growth and survival

Dato-DXd improves progression-free survival in patients with metastatic non-squamous NSCLC

UTHSC researcher part of team studying obesity-cancer connection

New nanoparticle-based system developed for comprehensive treatment of rheumatoid arthritis

New bioreactor could accelerate access to cancer-killing immunotherapy

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News